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Abstract: It is unclear if buccal cell samples contain sufficient human DNA with adequately sized fragments for high throughput 
genetic bioassays. Yet buccal cell sample collection is an attractive alternative to gathering blood samples for genetic epidemiologists 
engaged in large-scale genetic biomarker studies. We assessed the genotyping efficiency (GE) and genotyping concordance (GC) of 
buccal cell DNA samples compared to corresponding blood DNA samples, from 32 Nurses’ Health Study (NHS) participants using the 
Illumina Infinium 660W-Quad platform. We also assessed how GE and GC accuracy varied as a function of DNA concentration using 
serial dilutions of buccal DNA samples. Finally we determined the nature and genomic distribution of discordant genotypes in buccal 
DNA samples. The mean GE of undiluted buccal cell DNA samples was high (99.32%), as was the GC between the paired buccal and 
blood samples (99.29%). GC between the dilutions versus the undiluted buccal DNA was also very high (.97%), though both GE and 
GC notably declined at DNA concentrations less than 5 ng/µl. Most (.95%) genotype determinations in buccal cell samples were of the 
“missing call” variety (as opposed to the “alternative genotype call” variety) across the spectrum of buccal DNA concentrations   studied. 
Finally, for buccal DNA concentration above 1.7 ng/ul, discordant genotyping calls did not cluster in any particular   chromosome. 
  Buccal cell-derived DNA represents a viable alternative to blood DNA for genotyping on a high-density platform.
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Introduction
The use of genome-wide association studies (GWAS) 
as a means of detecting genetic biomarkers (single 
nucleotide polymorphisms (SNPs)) associated with 
disease typically requires large sample sizes, and the 
collection of DNA specimens from buccal samples 
represents an opportunity to minimize the involve-
ment of study personnel or ancillary services in the 
sample collection process. Furthermore, buccal cell 
sample  collection  is  minimally  invasive,  allowing 
study  subjects  to  collect  their  sample  from  home 
and send it back via the mail, which can maximize 
participation when the study population is geographi-
cally dispersed.1–6 However, inadequate DNA yield,3–6 
the presence of bacterial DNA,7 and the need to pos-
sibly store samples for long periods prior to use may 
compromise  the  utility  of  buccal  cell  samples  for 
GWAS.  Re-sampling  in  aging  cohorts  to  augment 
DNA concentrations may not be an option because of 
limited resources, loss to follow up, or death of cohort 
members.
Researchers have demonstrated the efficacy of 
buccal cell-derived DNA samples for use in genetic 
biomarker studies in low8–14 and moderately high 
density genotyping platforms (between 200,000 and 
400,000  single  nucleotide  polymorphisms),7,15–16 
but no study evaluated whether buccal cell DNA 
produces acceptable genotype efficiency and accu-
racy on higher density genotyping platforms. Such 
information may be useful to researchers deciding 
how to best utilize non-replenishable buccal cell 
repositories that may be depleted in the genotyping 
process.
In this study, we assessed genotyping efficiency 
and accuracy of paired buccal cell- and blood-  derived 
DNA samples from 32 Nurses’ Health Study (NHS) 
participants  genotyped  on  the  Illumina  Infinium 
660W-Quad genotyping platform. We also performed 
serial dilutions on a subset of buccal cell DNA samples 
to assess whether a genome-wide scan was   feasible at 
low DNA concentrations.
Materials and Methods
The  Nurses’  Health  Study  is  a  longitudinal cohort 
study  of  121,700  nurses  from  across  the  United 
States, with data collected since 1976.17 After IRB 
approval and informed consent from participants, we 
collected blood and buccal cells from a subset of NHS 
  participants, and randomly chose 32 individuals with 
both blood and buccal DNA for this study.
We collected blood samples from May 1989 to 
September  1990,  by  mailing  blood  collection  kits 
to participants; kits included mail back instructions 
and an icepack to facilitate return of samples via an 
overnight courier. We then separated buffy coat from 
red blood cells and plasma, and stored all fractions 
at the NHS Blood Lab in freezers at −130 °C. We 
later extracted DNA using QIAamp 96 DNA blood 
kit (Qiagen #51162).
We also collected buccal cells from participants by 
the mail from 2000 to 2002 and from 2004 to 2006. 
Participants used the “swish and spit” method, swish-
ing with 10 ml Scope® mouthwash for 30 seconds 
and spitting into a Nalgene sample cup that they then 
mailed back to the investigators within 24 hours of 
collection. Before processing, we stored the samples 
in their original vial at 4 °C for up to one week. We 
centrifuged  the  samples  and  extracted  DNA  from 
200 µl of the buccal pellet using QIAamp 96 DNA 
blood kit (Qiagen #51162). We then eluted DNA in 
200 µl Tris EDTA and stored it at −80 °C.
The blood and buccal cell samples were stored for 
a mean of 19.47 (range, 18.67–19.67) years, and 4.89 
(range, 4.33–5.25) years respectively. The mean age 
at blood draw was 53.64 (range, 43.33–68.33) years, 
and  the  mean  age  at  buccal  collection  was  68.23 
(range, 57.00–83.00) years.
We  measured  all  DNA  concentrations  with  the 
Quant-iT  PicoGreen  dsDNA  Assay  (Invitrogen 
P7589) at the Broad Institute, Cambridge, MA. The 
Broad Institute Genetic Analysis Platform (GAP) gen-
otyped 32 blood and 32 paired buccal samples, four 
buccal cell duplicates, and one HapMap control using 
the Sequenom iPLEX platform for a 24-SNP Finger-
Print panel (FP). We then loaded 4 µl of each sample 
for genotyping on the Illumina Infinium 660W-Quad 
genotyping platform and generated genotyping calls 
using the Illumina BeadStudio and Autocall software 
and  the  Illumina-provided  genotype  cluster  defini-
tions  file  (Human660W-Quad_v1_A.egt,  generated 
using HapMap project DNA samples).18
We  serially  diluted  a  randomly  selected  subset 
(n = 4) of the original buccal cell samples at 1:2, 1:4, 
1:8 and 1:16, and determined the concentrations by 
Picogreen  flourometry.  We  genotyped  the  diluted 
samples,  the  undiluted  samples  and  two  HapMap genome-wide genotyping using dNA from buccal cell samples
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controls on the Illumina Infinium 660W-Quad. We 
arrayed samples on the production plate so as to mini-
mize confounding by batch and processing effects.
To analyze the raw genotyping data, we used the 
programs PLATO19 and PLINK.20–21 For SNP   quality 
filtering, we pooled data from the two rounds of geno-
typing, and checked samples’ gender and relatedness. 
Of  the  657,366  total  SNPs,  we  removed  all  copy 
number variant loci (n = 64,527), SNPs that failed 
across all samples (n = 31,349), Y   chromosome SNPs 
(n = 8) and SNPs with coding discrepancies (n = 1), 
leaving 561,481 SNPs for analysis. For each sample, 
we calculated the genotype efficiency (GE) as the 
number  of  uncalled  SNPs  divided  by  561,481,  all 
subtracted from one. After removing filtered SNPs 
(n = 95,885), we calculated genotype concordance 
(GC) as the percentage of calls that were identical 
between  two  samples.  We  used  SAS  (v  9.1,  SAS 
Institute, Cary, NC) for statistical analysis, and as the 
data were not normally distributed (determined by the 
  Kolmogorov-Smirnov test) we used non-parametric 
tests in analysis. We tested the data from the paired 
blood and buccal samples with Wilcoxon signed-rank 
tests, and the associations between   dilutions or con-
centrations in relation to GE or GC with   Spearman’s 
rank  correlation  test.  We  considered  P  values 
, 0.05   statistically significant.
Results
As shown in Table 1, both sample types (blood and 
buccal)  showed  mean  genotype  efficiencies  (GEs) 
of .99%. All samples had GEs . 95%, and most 
samples  (100.00%  of  blood  and  93.75%  of  buc-
cal) had GEs . 98%. The mean GE was higher in 
blood (99.89%) compared to buccal samples (99.32%; 
P , 0.0001 for the difference in GE). The GE was 
not correlated with buccal DNA concentrations in the 
range 10–50 ng/µl (P = 0.09), nor was GE correlated 
with years of sample storage (P = 0.93 for blood, 
P = 0.92 for buccal) or age of participant at collec-
tion (P = 0.16 for blood, P = 0.35 for buccal). The 
mean  genotype  concordance  (GC)  between  buccal 
DNA and the blood DNA was extremely high (mean 
GC = 99.29 ± 0.60%).
In a second round of genotyping, serial dilutions 
(1:2, 1:4, 1:8, and 1:16) were made from four of the 
original 32 buccal cell samples. The mean concentra-
tions in these samples ranged from 1.10 ng/µl at the 
lowest dilution (1:16) to 31.63 ng/µl for the undiluted 
samples (Table 2). The mean GEs were still high, with 
only the lowest dilution showing values of ,98%. 
Nonetheless,  GEs  did  significantly  decrease  with 
either increasing DNA dilution (P = 0.04) or decreas-
ing DNA concentration (P = 0.02). GC also signifi-
cantly decreased with decreasing DNA concentration 
when either undiluted buccal cell DNA (P = 0.01) or 
the appropriate paired blood DNA sample was used 
as the reference (P = 0.03). However, even at the low-
est dilutions, the GC remained high (.97%).
As there were variations in DNA concentrations at 
each dilution, we also examined GE and GC as a func-
tion of DNA concentration in more detail. We divided 
samples into concentration ranges with an equal num-
ber of samples in each range. The mean GE and the 
mean GC (using the undiluted buccal DNA results as 
a reference to assess GC) as a function of DNA con-
centration range is illustrated in Figure. 1. Even at the 
lowest concentration range (#1.6 ng/µl), both mean 
Table 1. Genotype efficiency and concordance in matched buccal and blood samples from 32 women in the Nurses’ Health 
Study.
DnA source P value*
Blood (n = 32) Buccal (n = 32)
Mean concentration (Sd) (ng/µl) 45.96 (9.18) 43.04 (11.98) 0.13 
Concentration range (ng/µl) 14.82–50.00 10.00–50.00 –
Mean genotype efficiency (SD) (%)† 99.89 (0.05) 99.32 (0.57) ,0.0001
Genotype efficiency range (%)† 99.78–99.95 97.79–99.89 –
Mean concordance (SD) (%)‡ 99.29 (0.60) –
Concordance range (%)‡ 97.60–99.91 –
*P values from paired Wilcoxon tests of the differences between the paired blood and buccal samples.
†Genotype efficiency was calculated as 1-(number of called SNPs/561,481).
‡Concordance was calculated as the percentage of SNPs with identical calls between the two samples being compared.Loomis et al
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GE and mean GC were .97%; however, there was a 
notable decline for GE and GC below 4.6 ng/µl.
Although  overall  GCs  were  very  high  between 
diluted and undiluted samples, we explored the nature 
of  genotyping  discordances  (GDs)  that  occurred  at 
decreasing DNA concentrations. When compared to 
the genotyping calls from the undiluted buccal DNA 
sample, there were two general types of discordance: 
a “missing genotyping call”, (e.g. no genotype call vs. 
A/T, or vice versa), and a “different genotyping call” 
(e.g. A/A vs. A/T or T/T). Table 3 shows a breakdown 
of the type of GDs in each sample   dilution. Across all 
samples and dilutions, there were many more   “missing 
call”  than  “different  call”  discordances;  overall, 
96.95% of the GDs were of the “missing call” type, 
while only 3.05% of the GDs were of the “different 
call” type. The percentage of “different call” discor-
dances increased with greater dilution (P = 0.04).
To  further  quantify  the  SNP  discordances,  we 
assigned concordance scores to each SNP correspond-
ing to the number of individuals, out of four total, in 
which a SNP was discordant between the undiluted 
and diluted sample. We repeated this process for each 
concentration range. A score of 0 indicated that the 
SNP was concordant between the undiluted and diluted 
samples for none of the four individuals, and a score 
of 4 indicated that a SNP was concordant between 
diluted and undiluted samples for all four individuals. 
For samples with $10 ng/µl of DNA, 98.18% of SNPs 
were concordant with the undiluted sample in all four 
individuals, 1.35% of SNPs were concordant in three 
individuals, 0.38% of SNPs were concordant in two 
individuals, 0.08% of SNPs were concordant in only 
one individual, and 0.01% of SNPs were concordant 
to the undiluted sample in none of the individuals. 
The  percentages  of  SNPs  achieving  concordance 
scores from 0 to 4 at each dilution are summarized 
in a bar graph (see Fig. 2). For all four concentration 
ranges, the majority of SNPs showed concordance 
between  the  diluted  and  undiluted  sample  in  all 
four  individuals,  yet  as  concentration  decreased, 
the percentage of SNPs concordant across the four 
  individuals decreased.
To explore the origin of discordances, we found the 
chromosomal location of all discordant SNPs across 
Table 2. Concordance between serial dilutions of buccal dNA with paired undiluted buccal dNA and paired blood dNA 
among four women in the Nurses’ health Study.
Dilution Mean concentration 
(sD) (ng/μl)
Mean Ge  
(sD) (%)*
Mean concordance  
with undiluted buccal  
DnA (sD) (%)†
Mean concordance   
with blood DnA  
(sD) (%)†
1:1 (undiluted) 31.63 (18.52) 99.55 (0.23) n/a 99.46 (0.23)
1:2 15.83 (7.28) 99.46 (0.32) 99.38 (0.21) 99.36 (0.30)
1:4 7.20 (3.32) 99.32 (0.24) 99.25 (0.13) 99.22 (0.24)
1:8 3.18 (1.65) 98.17 (2.45) 98.07 (2.58) 97.96 (2.67)
1:16 1.10 (0.70) 97.57 (2.78) 97.44 (2.79) 97.35 (2.94)
P value‡ (by dilution) n/a 0.04 0.02 0.03
P value‡ (by concentration) n/a 0.02 0.01 0.03
*4 µl of each sample was loaded onto the Infinium platform; GE was calculated as 1-(number of called SNPs/561,481).
†Concordance was calculated as the percentage of SNPs with identical calls between the two samples being compared.
‡P values were derived from Spearman correlation tests between dilution or concentration in relation to ge or concordances.
Mean genotype efficiency and
concordance by concentration range
M
e
a
n
 
g
e
n
o
t
y
p
e
 
e
f
f
i
c
i
e
n
c
y
 
(
G
E
)
Concentration range (ng/ul)
M
e
a
n
 
c
o
n
c
o
r
d
a
n
c
e
 
(
G
C
)
100%
100%
99%
99%
98%
98%
97%
97%
96%
100%
100%
99%
99%
98%
98%
97%
97%
96%
0−1.6 1.7−4.5 4.6−1.0 10+
Mean GE Mean GC
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the genome and discovered that the discordance did 
not significantly cluster in any chromosome for all but 
the lowest DNA concentration range (P = 0.58–0.68 
for concentration ranges above 1.7 ng/µl). At lower 
DNA  concentrations,  however,  there  were  slightly 
more discordant SNPs on chromosomes 4, 5, 6 and 
18, which had discordant percentages $ 0.13% com-
pared  to  a  mean  discordant  percentage  of  0.10% 
across the genome overall.
Discussion
With the burgeoning interest in GWAS (see www.
genome.gov/gwastudies),22 there is an increased need 
to minimize costs and maximize patient participation 
for DNA collection since large sample sizes are typi-
cally necessary to detect associations between genetic 
biomarkers and complex traits of interest. Our study 
demonstrates that it is possible to adequately perform 
genotyping  on  a  high-density  genotyping  platform 
using  stored  DNA  from  buccal  cells  collected  by 
mail. In this study, 561,481 SNPs were genotyped at 
mean GE and GC . 98%, even when DNA concen-
trations were as low as 5 ng/ul. Nonetheless, while 
mean GE was .99% for both undiluted buccal and 
blood samples (Table 1), GE was significantly higher 
with DNA from blood samples, though the difference 
was small (0.57%).
In addition to showing that buccal cell DNA can be 
used for genome-wide genotyping, we also provide 
evidence  that  very  low  concentrations  of  archived 
buccal cell DNA produces high quality genotyping 
results, with high rates of genotyping calls (e.g. mean 
GE at the 1:4 dilution, where the mean DNA concen-
tration was 7.20 ± 3.22 ng/µl, was 99.32%). The high 
quality was also supported by the high concordance 
between the diluted and undiluted buccal samples and 
by the high concordance between diluted buccal and 
paired blood samples. The decline in GE and concor-
dance below 5 ng/µl indicates that 5 ng/µl may be 
a reasonable lower limit for achieving at least 99% 
GE with the Illumina Infinium 660K genotyping plat-
form. This has important implications for investiga-
tors with scarce or archived DNA samples, making 
it possible to maximize the usefulness of a limited 
sample (i.e. more information can be gained from a 
single sample with large-scale genotyping than from 
genotyping a finite panel of candidate SNPs).
Our in-depth analyses of the type and location of 
discordant SNPs showed that the discordances were 
predominantly of the “missing call” type as opposed 
Table 3. detailed analysis of discordant genotype calls among buccal cell samples at various diluted concentrations.
concentration  
(ng/μl)
concordance  
(%)*
Mean number of discordant snps (%)
All discordances Missing call Different call
10+ 99.40 3372 3306 (97.94) 66 (2.06)
4.6–10 99.31 3889 3809 (97.90) 80 (2.10)
1.7–4.5 98.08 10762 10129 (96.21) 634 (3.79)
0–1.6 97.35 14874 14196 (95.76) 679 (4.24)
P value† – – 0.04
*Concordance was calculated as the percentage of SNPs with identical calls between the dilutions and the undiluted samples.
†P values were derived from Spearman correlation tests between concentration and percentage of different calls. explanations for missing calls and 
different calls are provided in the text.
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to the “different call” type. This most likely indicates 
that the Illumina platform has rigorous requirements 
for  call  quality,  such  that  at  lower  concentrations, 
a SNP will not be called if there is doubt about the 
  accuracy of the call. The small number of   different 
calls relative to missing calls means that at low con-
centrations, data will more likely be lost rather than 
be false, thereby limiting misleading genotyping calls. 
Also, discordances did not cluster on any particular 
chromosome  for  concentration  ranges  .1.6  ng/µl, 
indicating that the decrease in genotype calling qual-
ity with decreased concentration occurred randomly 
across  the  genome,  except  at  very  low  concentra-
tions. Because concordance increases as concentra-
tion decreases, the clustering that occurred at very 
low concentrations is likely due to a greater num-
ber of discordant SNPs overall and chance that they 
occurred on specific chromosomes.
A limitation to our study is that the genotyping 
on buccal DNA was conducted only on the Illumina 
Infinium 660W-Quad platform. While other platforms 
may  perform  equally  as  well,  further  studies  are 
needed before extending these data for use on other 
platforms. In addition, our sample size was relatively 
small, but despite this, we were still able to detect sig-
nificant differences in GE between blood and buccal 
cell  samples.  Furthermore,  we  were  able  to  detect 
trends in GE and concordance as a function of DNA 
concentration. Finally, buccal samples were stored for 
a mean of 4 years and we do not know what the effect 
of longer storage periods would be on GE and GC.
In conclusion, we have shown that buccal cell DNA 
is a viable alternative to blood DNA for genome-wide 
genotyping, and that low DNA concentrations can be 
used for genotype determination on high-throughput 
genome-wide  scan  platforms.  Genotype  efficiency 
and concordance does decline with DNA concentra-
tion on the Illumina platform, and genotyping on the 
Illumina platform may suffer at DNA concentrations 
below 5 ng/µl; therefore, we recommend using higher 
concentrations if available.
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